Homepage | Welcome
Officers | Executive Committee
Sections | Working Groups
Member Societies
Awards & Honours
ISC Committees
ISC-on-LINE
International Journal of Antimicrobial Agents
Future Meetings
Past Meetings
  2010
  2009
  2008
  2007
  2006
  2005
Contact
FeedbacK
Site Information

Welcome ISC

INTERNATIONAL SOCIETY OF CHEMOTHERAPY
<INFECTION and CANCER>
The International Society of Chemotherapy (ISC) is a non-profit organisation
and is a charity registered in the UK. 

The ISC was started by the late Professor Helmut Kuemmerle of Germany in 1959 in a railway station in Geneva, Switzerland. The 1st International Symposium of Chemotherapy was held in Geneva in the same year but it was not until 1961 that the ISC was formally established on the occasion of the 2nd International Symposium of Chemotherapy held in Naples, Italy. The third meeting in Stuttgart in 1963 was renamed the International Congress of Chemotherapy and this has remained its title ever since. The congresses have continued to be held every two years and 2011 sees the 27th ICC held in collaboration with the 21st ECCMID. 2011 also marks the 50th anniversary of the ISC.

In 1971, at the 7th ICC held in Prague, the Ministry of Health of the Czech Republic presented the ISC with a plaque (left) to serve as an historic emblem of the society. They proposed that the plaque should be moved from congress to congress and displayed as a perpetual reminder of past congresses and as an inspiration for even better future meetings.
The ISC aims to advance the education and the science of therapy of infection and of cancer through the establishment of an international federation of affiliated national and regional societies with similar aims and objectives to its own. The ISC currently has a worldwide membership composed of 85 national and regional societies, which in turn have over 50,000 individual members. The Member Societies hold their own congresses which are supported by the ISC.

The ISC promotes the conduct of scientific research, convening international congresses, conferences and symposia and encourages co-operation within the society and between scientists belonging to other societies dealing with related basic and clinical sciences. In the last decade, most of the society work has been on antimicrobials.
The ISC currently has 17 Working Groups / Sections and actively encourages and/or sponsors the formation of international working groups for special research, training projects or the use of therapeutics in the field of anti-infective and anti-neoplastic therapy and co-ordinating their activities. The Working Groups contribute significantly to the ISC Disease Management Series of meetings. In addition, the ISC awards scholarships and bursaries to enable attendance at and travel to its international congresses.The Society is governed by its Trustees, Executive Committee and Council which are led by Professor Teresita Mazzei, ISC President. The ISC Council consists of representatives of ISC Member Societies and meets at least every two years during the ICCs.

The Society’s official journal is the International Journal of Antimicrobial Agents and Chemotherapy (IJAA). It recently saw an increase in Impact Factor to over 3 under the expert guidance of the Editor-in-Chief: Professor Alasdair Geddes.

DISCLAIMER

Occasionally, other societies use the ISC logo when holding joint meetings with the ISC or when organising meetings under the auspices of the ISC. Permission to use the ISC logo may only be granted by the ISC President.

Permission to use the logo of the ISC may be granted on condition that the ISC does not thereby undertake any liabilities for the event, or from anything that takes place at or following the event.

Display of the logo does not signify that the ISC endorses all, or any, of the content of the event where the logo is used.  

International Journal of Antimicrobial Agents (newly announced impact factor = 3.1)

One of ISC’s principle activities is production of the International Journal of Antimicrobial Agents in collaboration with the publisher Elsevier.

The journal provides comprehensive and up-to-date peer reviewed reference information on the physical, pharmacological, in vitro and clinical properties of individual antimicrobial agents. In addition, it signals new trends and developments in the field through highly authoritative review articles on antimicrobial agents, immunomodulators and immunotherapy. Special attention is given to articles providing insight into the problems of antimicrobial resistance, local as well as world-wide, both in the hospital and in the community. Papers on the underlying mechanisms and on immunomodulating agents are also welcome. Both solicited reviews by top experts in the mentioned fields and high-quality original research papers are published.

The journal is thriving due, in no small part, to the diligence of our Editor-in-Chief: Professor Alasdair Geddes, Birmingham, UK. Professor Geddes is also one of the ISC Trustees. During the recent ICC, it was announced that the impact factor of the journal had risen to 3.1. Well done to Professor Geddes and his team.

Note * ISC member societies can take advantage of reduced subscription rates. For further information go to the International Journal of Antimicrobial Chemotherapy click here.

Manuscripts may be submitted via http://ees.elsevier.com/IJAA

Last edition : mars 30, 2010

International Society of Chemotherapy
webdesign cos